Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial

Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial

Bibliographic Details
Main Authors: Neychev, Vladimir, Steinberg, Seth M, Cottle-Delisle, Candice, Merkel, Roxanne, Nilubol, Naris, Yao, Jianhua, Meltzer, Paul, Pacak, Karel, Marx, Stephen, Kebebew, Electron
Format: Online
Language:English
Published: BMJ Publishing Group 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442235/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442235/

Similar Items